Latest AI and machine learning research in diabetes for healthcare professionals.
Diabetes represents an emerging global health crisis, with lower-middle-income countries experiencing a fast growth in prevalence. Diabetes care in these regions often faces significant challenges, including inadequate healthcare infrastructure, limited financial resources, a shortage of trained healthcare personnel, and a dual burden of communicable and non-communicable diseases. Artificial intel...
This study explores Artificial Intelligence (AI)’s transformative role in diabetes care and monitoring, focusing on innovations that optimize patient outcomes. AI, particularly machine learning and deep learning, significantly enhances early detection of complications like diabetic retinopathy and improves screening efficacy. The methodology employs a bibliometric analysis using Scopus, VOSviewer,...
This review explores the transformative role of artificial intelligence (AI) in the early detection and prognosis prediction of diabetic retinopathy (...
To evaluate whether machine learning models trained solely on administrative and demographic data can predict inpatient APR Risk of Mortality in diabe...
Artificial intelligence (AI) in chronic disease prediction often exhibits algorithmic biases, hindering equitable healthcare delivery. This study aims...
Histological analysis of kidney biopsies is crucial in diagnosing kidney diseases and predicting clinical outcomes. Recently developed pathology found...
Accurate and interpretable forecasting of blood glucose levels is critical for effective manage- ment of Type 2 diabetes. While complex machine learni...
With rapid urbanization, lifestyle changes, and an aging population, non-communicable diseases (NCDs), including hypertension and diabetes, pose signi...
This paper presents a hybrid model combining fuzzy logic, recursive feature elimination (RFE), and logistic regression to predict type 2 diabetes mell...
BK polyomavirus-associated nephropathy (BKPyVAN) is a serious complication of kidney transplantation. Numerous kidney diseases such as BKPyVAN have be...
Long-term management of chronic diseases such as diabetes is increasingly based on wearable technologies, particularly continuous glucose monitoring (...
In cardiovascular magnetic resonance (CMR), myocardial native T1 mapping enables quantitative, non-invasive tissue characterization and is sensitive t...
Type 2 diabetes (T2D) is a complex and clinically heterogeneous disease. Although clustering approaches have defined clinical subtypes, their genetic ...
Obesity, a leading global risk factor for cardiometabolic conditions, arises from multifaceted and biologically complex mechanisms1,2. To elucidate th...
Cystic fibrosis-related diabetes (CFRD) affects up to 60% of adults with CF and contributes to poorer clinical outcomes, including accelerated lung de...
Medication non-adherence remains a significant challenge in managing chronic conditions like diabetes and hypertension, leading to increased morbidity...
Hepatic steatosis (HS) is a common cardiometabolic risk factor frequently present but under-diagnosed in patients with suspected or known coronary art...
To quantify spectral-domain optical coherence tomography (SD-OCT) images cross-sectionally and longitudinally in a large cohort of molecularly charact...
Artificial Intelligence (AI) has evolved through various trends, with different subfields gaining prominence over time. Currently, Conversational Arti...
Synthetic data generated using generative models trained on real clinical data offers a promising solution to privacy concerns in health research. How...